Table 4.
Baseline characteristics of patient comparing intervention group and control group.
| First Author (Year) | Intervention | Number of Enrollment | Number of Completion | Mean (SD) Age at Baseline (Year) | BMI Mean (SD) In kg/m2 at Baseline |
Duration (Mean Week) | Completion Rate on Diets at the End of Trial (%) |
|---|---|---|---|---|---|---|---|
| OK (2018) | KD GD |
20 10 |
10 9 |
57.8 (7.3) 66.3 (9.8) |
24.0 (2.2) 22.2 (2.6) |
4 | 50.0 90.0 |
| Cohen (2018) | KD ACS |
37 36 |
25 20 |
61.5 (8.5) 58.6 (11.7) |
30.7 (8.0) 33.0 (10.7) |
12 | 55.6 67.6 |
| Cohen (2020) | KD ACS |
37 36 |
25 20 |
61.5 (8.5) 58.6 (11.7) |
30.7 (8.0) 33.0 (10.7) |
12 | 55.6 67.6 |
| Khodabakhshi (2019) | KD SD |
40 37 |
30 30 |
44.8 (8.4) 45.2 (15.0) |
28.47 (4.1) 28.44 (5.8) |
12 | 75.0 81.1 |
| Kang (2019) | LCKD GD |
20 10 |
9 9 |
58.3 (7.6) 66.3 (9.8) |
24.0 (2.2) 22.2 (2.7) |
4 | 45.0 90.0 |
| Freedland (2019) | LCD GD |
20 22 |
11 18 |
67.8 (12.7) 63.8 (11.3) |
31.9 (9.5) 29.4 (4.0) |
24 | 55.0 81.8 |
Abbreviations: ACS, American Cancer Society diet; BMI, body mass index; GD, general diet; KD, ketogenic diet; LCD, low-carbohydrate diet; LCKD, low-carbohydrate ketogenic diet; MCT, medium chain triglycerides; SD, standard diet.